| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |